US stocks are landing at Stockopedia Find out more
Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value

Margin of Safety (beta)
Screens Passed
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2008 2009 2010 2011 2012 2013 2014E 2015E CAGR / Avg
Revenue $m
Operating Profit $m
Net Profit $m
EPS Reported $
EPS Normalised $
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps $
Capex ps $
Free Cashflow ps $
Dividends
Dividend ps $
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc $m
Working Capital $m
Net Fixed Assets $m
Net Debt $m
Book Value $m
Average Shares m
Book Value ps $ -27.0%

FINANCIAL BRIEF: For the fiscal year ended 31 December 2013, MDxHealth SA revenues increased 28% to $7.6M. Net loss increased 40% to $16.2M. Revenues reflect Product and Service Income increase of 58% to $7.6M. Higher net loss reflects Labour Expenses increase of 76% to $8.6M (expense), Depreciation/Amortization in SGA increase from $69K to $248K (expense), Other Operating Charges(1) increase from $14K to $193K (expense). more »

Health Trend

Bankruptcy Risk

  Earnings Manipulation Risk

Magic Formula Score

Other Ratios
Leverage (ttm) Total Ex Intang
Gross Gearing %
Net Gearing %
Cash / Assets %

vs.
market
vs.
industry
Recent History
Latest interim period (ended 31st Dec '13) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2014
31st Dec 2015

Price Target: €3.50 (+0.81% above Price) Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (€) (€) (€) (€) (€) (€)
Consensus Estimate
1m Change
3m Change
1 brokers Broker Consensus Trend
Broker Recommendations for MDxHealth SA
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 0 0 1 0 1

Named Brokers and Analysts
ING FM Luke Poloniecki , Petercam (Historical) Roderick Verhelst ,

MDxHealth SA (formerly known as OncoMethylome Sciences SA) is a Belgium-based biotech company dedicated to the development and commercialization of molecular diagnostic tests for early cancer detection and personalized treatment decisions. The Company develops deoxyribonucleic acid (DNA) gene methylation tests to assist physicians in detecting cancer at an early stage and in predicting a patient’s response to cancer therapy or the likelihood of cancer recurrence. The Company develops cancer diagnostic products and personalized medicine tests for different types of cancers, such as prostate cancer, colon cancer and lung cancer. The Company’s subsidiaries include OncoMethylome Sciences BV in the Netherlands, MDxHealth Inc. in the United States and MDxHealth PharmacoDx BVBA in Belgium.

Directors: Jan Groen (CEO) , Joseph Sollee (EVP) 48, Christopher Thibodeau (EVP) 42, Wim van Criekinge (CSO) , Francis Ota (VFN) 60, Miriam Reyes (VOP) , Joseph Bigley (VPR) , Ming-Chou Lee (VPR) , Edward Erickson (NEC) 68, Rudi Marien (NED) 69, Rudi Pauwels (IND) 52, R. Devenyns (NID) 48, Mark Myslinski (NID) 58,

No. of Employees: 84 No. of Shareholders: 0


Last Annual December 31st, 2013
Last Interim June 30th, 2013
Shares in Issue 34,251,303
ISIN BE0003844611
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Euronext - Brussels
Eligible for an ISA? a SIPP?

MDXH Share Price Performance MDXH Quote
€3.48
0.0  0.2%
Traded 3:40pm · Minimum 15 min delayed · NMS:

Latest MDXH News Announcements (delayed)

Upcoming MDXH Events
Thursday 21st August, 2014
Q2 2014 MDxHealth SA Earnings Release
Tuesday 4th November, 2014
Q3 2014 MDxHealth SA Earnings Release
Friday 29th May, 2015 (estimate)
MDxHealth SA Annual Shareholders Meeting

Recent ↓
Friday 30th May, 2014
MDxHealth SA Extraordinary Shareholders Meeting
Monday 26th May, 2014 (estimate)
MDxHealth SA Annual Shareholder Meeting
Thursday 20th March, 2014
MDxHealth SA at KBC Healthcare Conference
Tuesday 4th March, 2014
MDxHealth SA at Sachs Associates EUROPEAN LIFE SCIENCE CEO FORUM PARTNERING & INVESTING IN BIOTECH & PHARMA INDUSTRY Conference
Monday 24th February, 2014 (estimate)
Q4 2013 MDxHealth SA Earnings Release
Monday 13th January, 2014
MDxHealth SA at JPMorgan Healthcare Conference
Thursday 14th November, 2013
MDxHealth SA at KBC Benelux Biotech & Healthcare Seminar
Wednesday 6th November, 2013
Q3 2013 MDxHealth SA Earnings Release
Thursday 22nd August, 2013
Q2 2013 MDxHealth SA Earnings Release
Thursday 27th June, 2013
MDxHealth SA Extraordinary Shareholder Meeting


Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2014.


Should you buy MDXH

Access MDXH Analytics Now!

FREE TRIAL or TAKE THE TOUR